Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas.
J Endocrinol Invest
; 42(4): 443-451, 2019 Apr.
Article
in En
| MEDLINE
| ID: mdl-30171531
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Preoperative Care
/
Somatostatin
/
Magnetic Resonance Spectroscopy
/
Adenoma
/
Receptors, Somatostatin
/
Growth Hormone-Secreting Pituitary Adenoma
/
Hormone Antagonists
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Endocrinol Invest
Year:
2019
Type:
Article
Affiliation country:
China